Charlotte Dahle

2.6k total citations
69 papers, 1.8k citations indexed

About

Charlotte Dahle is a scholar working on Pathology and Forensic Medicine, Immunology and Rheumatology. According to data from OpenAlex, Charlotte Dahle has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 23 papers in Immunology and 22 papers in Rheumatology. Recurrent topics in Charlotte Dahle's work include Multiple Sclerosis Research Studies (24 papers), Systemic Lupus Erythematosus Research (20 papers) and Peripheral Neuropathies and Disorders (11 papers). Charlotte Dahle is often cited by papers focused on Multiple Sclerosis Research Studies (24 papers), Systemic Lupus Erythematosus Research (20 papers) and Peripheral Neuropathies and Disorders (11 papers). Charlotte Dahle collaborates with scholars based in Sweden, United Kingdom and United States. Charlotte Dahle's co-authors include Magnus Vrethem, Jan Ernerudh, Johan Mellergård, Jan Lycke, Fredrik Piehl, Anders Svenningsson, Tomas Olsson, Irene Håkansson, Thomas Skogh and Kaj Blennow and has published in prestigious journals such as Blood, PLoS ONE and Annals of Neurology.

In The Last Decade

Charlotte Dahle

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte Dahle Sweden 21 900 596 400 372 283 69 1.8k
Laure Michel France 25 793 0.9× 1.1k 1.8× 247 0.6× 146 0.4× 252 0.9× 68 2.0k
Astrid Rasmussen United States 27 462 0.5× 443 0.7× 486 1.2× 778 2.1× 1.4k 4.9× 76 4.1k
Ian Sutton Australia 20 363 0.4× 542 0.9× 814 2.0× 164 0.4× 352 1.2× 43 2.0k
Anna Brunn Germany 28 612 0.7× 285 0.5× 799 2.0× 118 0.3× 393 1.4× 84 2.0k
Arumugam Palanichamy United States 13 979 1.1× 1.3k 2.2× 350 0.9× 447 1.2× 303 1.1× 17 2.4k
Noriko Isobe Japan 25 1.3k 1.5× 548 0.9× 974 2.4× 546 1.5× 510 1.8× 129 2.4k
Stanley Hawkins United Kingdom 22 818 0.9× 485 0.8× 214 0.5× 336 0.9× 187 0.7× 64 1.4k
John S. Tzartos Greece 15 788 0.9× 955 1.6× 340 0.8× 231 0.6× 323 1.1× 69 2.0k
Amanda K. Huber United States 26 354 0.4× 894 1.5× 86 0.2× 268 0.7× 498 1.8× 49 2.3k
F. Jouen France 25 346 0.4× 290 0.5× 181 0.5× 691 1.9× 481 1.7× 60 1.9k

Countries citing papers authored by Charlotte Dahle

Since Specialization
Citations

This map shows the geographic impact of Charlotte Dahle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Dahle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Dahle more than expected).

Fields of papers citing papers by Charlotte Dahle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Dahle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Dahle. The network helps show where Charlotte Dahle may publish in the future.

Co-authorship network of co-authors of Charlotte Dahle

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Dahle. A scholar is included among the top collaborators of Charlotte Dahle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Dahle. Charlotte Dahle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wirestam, Lina, Charlotte Dahle, Martina Frodlund, et al.. (2024). Screening for autoimmune diseases in apparently healthy antinuclear antibody positive individuals. Frontiers in Medicine. 11. 1455673–1455673. 2 indexed citations
2.
Dahle, Charlotte, et al.. (2023). Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 24(12). 10398–10398. 2 indexed citations
3.
Wirestam, Lina, et al.. (2023). Serum levels of soluble urokinase plasminogen activator receptor in juvenile idiopathic arthritis: a single-center Swedish case-control study. Pediatric Rheumatology. 21(1). 49–49. 1 indexed citations
4.
Dahle, Charlotte, et al.. (2022). Autoantibodies Associated with Autoimmune Liver Diseases in a Healthy Population: Evaluation of a Commercial Immunoblot Test. Diagnostics. 12(7). 1572–1572. 3 indexed citations
5.
Huang, Yu-Min, et al.. (2022). OCT and VEP correlate to disability in secondary progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 68. 104255–104255. 6 indexed citations
6.
Frodlund, Martina, Lina Wirestam, Örjan Dahlström, et al.. (2021). Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study. Journal of Clinical Medicine. 10(17). 3820–3820. 7 indexed citations
7.
8.
Håkansson, Irene, Jan Ernerudh, Magnus Vrethem, Charlotte Dahle, & Kristina Nilsson Ekdahl. (2020). Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis. Journal of Neuroimmunology. 340. 577147–577147. 11 indexed citations
9.
Forsberg, Lars, Anna Fält, Å. Berglund, et al.. (2019). Clinical effectiveness of dimethyl fumarate with focus on patients treated at least 36 months - a Swedish nationwide study of the long-term effectiveness and safety of dimethyl fumarate (IMSE5). Multiple Sclerosis Journal. 25. 316–317. 1 indexed citations
10.
Fält, Anna, Å. Berglund, Jan Hillert, et al.. (2018). A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5). Multiple Sclerosis Journal. 24. 699–700. 4 indexed citations
11.
Dahle, Charlotte, Jasmin Knopf, Rostyslav Bilyy, et al.. (2018). Active NET formation in Libman–Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus. Autoimmunity. 51(6). 310–318. 15 indexed citations
12.
Danielsson, Olof, Björn Lindvall, Claes Hallert, Magnus Vrethem, & Charlotte Dahle. (2017). Increased prevalence of celiac disease in idiopathic inflammatory myopathies. Brain and Behavior. 7(10). e00803–e00803. 11 indexed citations
13.
Johansson, Sverker, Lars Forsberg, Jan Hillert, et al.. (2015). A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab. Multiple Sclerosis Journal. 21. 285–286. 1 indexed citations
14.
Dahle, Charlotte, Magnus Vrethem, Mika Gustafsson, et al.. (2014). Regulatory T cells in Multiple Sclerosis – Indications of impaired function of suppressive capacity and a role for chemokines. Health Policy and Planning. 18(4). 421–8. 1 indexed citations
15.
Wang, Ning, Lennart Truedsson, Kerstin Elvin, et al.. (2014). Serological Assessment for Celiac Disease in IgA Deficient Adults. PLoS ONE. 9(4). e93180–e93180. 29 indexed citations
16.
Jönsson, Lars, Fredrik Piehl, Jan Hillert, et al.. (2013). The immunomodulation and multiple sclerosis epidemiology (IMSE) study; a Swedish nationwide pharmaco-epidemiological and genetic study focussed on long-term safety and efficacy of natalizumab (Tysabri). Multiple Sclerosis Journal. 19(11). 205–205. 4 indexed citations
17.
18.
Dahle, Charlotte, et al.. (2010). Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase. Alimentary Pharmacology & Therapeutics. 32(2). 254–260. 39 indexed citations
19.
Dahle, Charlotte, Maha Mustafa, Rayomand Press, et al.. (1998). Recovery from Guillain–Barré Syndrome Is Associated with Increased Levels of Neutralizing Autoantibodies to Interferon-γ. Clinical Immunology and Immunopathology. 88(3). 241–248. 18 indexed citations
20.
Dahle, Charlotte, Christina Ekerfelt, Magnus Vrethem, Margareta Samu­elsson, & Jan Ernerudh. (1997). T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome. Journal of the Neurological Sciences. 153(1). 54–60. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laure Michel Breakdown of academic impact, for papers by Astrid Rasmussen Breakdown of academic impact, for papers by Ian Sutton Breakdown of academic impact, for papers by Anna Brunn Breakdown of academic impact, for papers by Arumugam Palanichamy Breakdown of academic impact, for papers by Noriko Isobe Breakdown of academic impact, for papers by Stanley Hawkins Breakdown of academic impact, for papers by John S. Tzartos Breakdown of academic impact, for papers by Amanda K. Huber Breakdown of academic impact, for papers by F. Jouen
Rankless by CCL
2026